Zoledronic acid restores doxorubicin chemosensitivity and immunogenic cell death in multidrug-resistant human cancer cells. [electronic resource]
- PloS one 2013
- e60975 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Retracted Publication
1932-6203
10.1371/journal.pone.0060975 doi
ATP Binding Cassette Transporter, Subfamily B ATP Binding Cassette Transporter, Subfamily B, Member 1--metabolism CD8-Positive T-Lymphocytes--drug effects Cell Death--drug effects Cell Line, Tumor Cholesterol--biosynthesis Dendritic Cells--drug effects Diphosphonates--pharmacology Down-Regulation--drug effects Doxorubicin--pharmacology Drug Resistance, Multiple--drug effects Drug Resistance, Neoplasm--drug effects Drug Screening Assays, Antitumor Extracellular Signal-Regulated MAP Kinases--metabolism Humans Hypoxia-Inducible Factor 1, alpha Subunit--metabolism Imidazoles--pharmacology Mevalonic Acid--metabolism Models, Biological Phagocytosis--drug effects Prenylation--drug effects Protein Kinase Inhibitors--pharmacology Signal Transduction--drug effects Terpenes--metabolism Zoledronic Acid ras Proteins--metabolism rho-Associated Kinases--metabolism